""Therapeutic cloning will hopefully be the solution for all the problems that have plagued transplant medicine for many years -- the shortage of tissue and rejection. Stem cells lines are basically immortal and with them we can turn them into any cell type," Robert Lanza, chief scientist for Advance Cell Technology, a U.S. company involved in regenerative medicine."
January 1, 1970